Avalon Trust’s Stride LRN Stock Holding History

Avalon Trust’s Portfolio LRN Stock Details LRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-82	Closed	-$12.2K	–	555
2025 Q3	$12.2K	Hold	82	–	–	﹤0.01%	409
2025 Q2	$11.9K	Hold	82	–	–	﹤0.01%	341
2025 Q1	$10.4K	Hold	82	–	–	﹤0.01%	361
2024 Q4	$8.52K	Hold	82	–	–	﹤0.01%	327
2024 Q3	$7K	Hold	82	–	–	﹤0.01%	295
2024 Q2	$5.78K	Hold	82	–	–	﹤0.01%	293
2024 Q1	$5.17K	Hold	82	–	–	﹤0.01%	301
2023 Q4	$4.87K	Hold	82	–	–	﹤0.01%	311
2023 Q3	$3.69K	Buy	+82	New	+$3.33K	﹤0.01%	289

Other funds holding LRN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Avalon Trust's LRN Position: Q4 2025 in Review

Avalon Trust sold out of Stride (LRN) in Q4 2025, closing a stake of 82 shares — an estimated $12.2K sold.

Avalon Trust first reported a position in LRN in Q3 2023 and held it in 9 quarters. The position peaked at $12.2K in Q3 2025. 397 funds tracked by Wall St. Rank hold LRN as of Q4 2025.

Avalon Trust reported no remaining Stride position as of Q4 2025 after selling out during the quarter.
Avalon Trust sold 82 Stride shares in Q4 2025, an estimated $12.2K.
Avalon Trust first reported a position in Stride in Q3 2023 and held it in 9 quarters.
Avalon Trust's Stride position peaked at $12.2K in Q3 2025.
397 funds tracked by Wall St. Rank held Stride as of Q4 2025.

Based on Avalon Trust's 13F filing for Q4 2025, filed 9 Feb 2026.